Better Therapeutics Inc (OQ:BTTX)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for BTTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 13/24 Feb 9/24 Perry David P Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 839,895 $0.191
Jan 10/24 Jan 9/24 Perry David P Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,471,453 $0.170
Dec 20/23 Dec 18/23 Perry David P Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Carmona Richard H Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Lavizzo-Mourey Risa J Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Wynholds Kristin Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,362  
Dec 20/23 Dec 18/23 Parker Geoffrey M. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Armanino Andrew J. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Miller Leslie A. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,587  
Dec 20/23 Dec 18/23 Granger Elder Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BTTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 13/24 Feb 9/24 Perry David P Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 839,895 $0.191
Jan 10/24 Jan 9/24 Perry David P Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,471,453 $0.170
Dec 20/23 Dec 18/23 Perry David P Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Carmona Richard H Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Lavizzo-Mourey Risa J Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Wynholds Kristin Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,362  
Dec 20/23 Dec 18/23 Parker Geoffrey M. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Armanino Andrew J. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Dec 20/23 Dec 18/23 Miller Leslie A. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,587  
Dec 20/23 Dec 18/23 Granger Elder Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,750  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BTTX

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
Disc Medicine (OQ:IRON)
Moderna (OQ:MRNA)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.